About this trial
Severe mental disorders such as schizophrenia, bipolar disorder, and psychotic depression often require long-term or lifelong medication treatment. However, many psychiatric patients have difficulty adhering to their prescribed medication regimens due to factors such as lack of information, fear of side effects, and negative experiences with psychotropic medications. Poor treatment adherence is associated with symptom relapse, prolonged hospitalization, increased rehospitalization rates, reduced quality of life, and higher health care costs.
Medication education is a key psychosocial intervention aimed at improving patients' understanding of their illness, treatment process, and potential medication side effects. Providing structured medication education may enhance treatment adherence and help patients recognize and manage side effects more effectively.
This intervention study aims to evaluate the effect of a structured medication education program on treatment adherence and medication-related side effects among psychotic inpatients hospitalized in a psychiatric clinic, including patients diagnosed with schizophrenia, schizoaffective disorder, schizophreniform disorder, bipolar disorder with psychotic features, and major depressive disorder with psychotic features. The findings of this study are expected to contribute to the development of effective psychosocial interventions to improve medication adherence and treatment outcomes in psychiatric inpatient settings.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Adults aged 18-65 years
Hospitalized in a psychiatric inpatient clinic
Diagnosed with schizophrenia, schizoaffective disorder, schizophreniform disorder, bipolar disorder with psychotic features, or major depressive disorder with psychotic features
Receiving psychotropic medication treatment
Disqualifiers
Presence of severe cognitive impairment or intellectual disability
Acute medical or neurological conditions that may interfere with participation
Severe agitation or acute psychotic symptoms preventing participation
Hearing or communication impairments that limit participation in educational sessions
Trial design
Parallel
Treatments tested in this trial
Medication Education Program
BehavioralStructured medication education provided in addition to routine psychiatric inpatient care.
Routine Psychiatric Inpatient Care
BehavioralStandard psychiatric inpatient care including pharmacological treatment and routine nursing care provided according to hospital protocols. No additional medication education is provided.
Treatment groups
Trial outcomes
Primary outcomes
Treatment Adherence
Treatment adherence will be assessed by evaluating patients' adherence to prescribed psychotropic medications, including regular medication use and compliance with the treatment regimen, using a validated medication adherence assessment tool.
Secondary outcomes
Medication-Related Side Effects
Medication-related side effects will be assessed by evaluating the presence, frequency, and severity of psychotropic medication side effects using a validated side effect assessment scale.
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: